Rekha V. Kumar

This study presents whole-genome and transcriptome analyses of breast tumors from India, identifying novel mutations, copy number alterations, and subtypes with clinical implications.

This study identifies LOX as a key mediator of TGF-β-induced myCAF state in breast cancer, showing its role in promoting tumor growth through a LOX/FAK/GSK3β/β-catenin pathway.

This study shows that noncanonical PAR1 activation by HAP induces autophagy in breast cancer cells, which inhibits tumor growth and delays carcinogenesis in a mouse model.